Juliette

Tibolone, the active ingredient in Juliette, is a synthetic steroid presented as an oral tablet for oral use. It relieves menopausal symptoms and helps prevent osteoporosis in postmenopausal women.\n\nGNH India supplies Juliette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Juliette is a synthetic steroid that acts on estrogen, progestogen and androgen pathways to manage menopause‑related conditions.\n\n- Menopausal vasomotor symptoms: reduces hot flashes and night sweats.\n- Menopausal mood disturbances: improves mood and sleep quality.\n- Postmenopausal osteoporosis: helps maintain bone mineral density.

Common side effects are generally mild and transient.\n\nCommon Side Effects:\n- Nausea\n- Headache\n- Breast tenderness\n- Weight gain\n- Mood changes\n\nSerious or Rare Side Effects:\n- Deep vein thrombosis\n- Pulmonary embolism\n- Liver dysfunction

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.\n\n- Assess cardiovascular risk: review history of thromboembolic disease.\n- Monitor bone health: obtain baseline densitometry.\n- Screen for hormone‑sensitive cancers: consider prior history.\n- Avoid in active liver disease: contraindicated.\n- Store at ambient temperature: keep in the original pack, protect from moisture.

Tibolone may interact with several drug classes; some combinations should be avoided while others require close monitoring.\n\nMajor Interactions (Avoid):\n- Combined estrogen therapy: increased risk of thromboembolism.\n- Anticoagulants: may reduce anticoagulant efficacy.\n- CYP450 inducers (e.g., rifampicin): may lower tibolone plasma levels.\n\nModerate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors: possible additive mood effects.\n- Tamoxifen: antagonistic effect on estrogen receptors.\n- Carbamazepine: may decrease tibolone concentrations.